MADISON HEIGHTS, Mich., May 20, 2025 /PRNewswire/ -- Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology, today announced a strategic partnership with Lumea, the leader in digital pathology and AI-powered workflow innovation–advancing efficient, precise, and accessible diagnostics across the pathology ecosystem.
This collaboration reflects both companies' shared mission to simplify and modernize pathology workflows to improve diagnostic accuracy. By integrating Lumea's BxCamera® directly into Mopec Group's advanced Maestro® Encore grossing stations, the partnership empowers pathologist professionals with high-resolution imaging and digital tools right at the first step of specimen preparation – streamlining processes, enhancing consistency, and improving diagnostic outcomes.
This collaboration represents an important milestone in Mopec Group's broader strategy to transform the grossing station into the pathology command center. By integrating Lumea's AI-assisted imaging technology for small specimens, Mopec Group is building upon its existing large-specimen imaging capabilities—taking a deliberate step toward a fully digital, intelligent, and connected lab environment.
"This partnership is a strategic step in advancing the grossing station toward the future of digital pathology," said Francis X. Dirksmeier, CEO of Mopec Group. "With integrated large-specimen imaging already in place, adding Lumea's AI-assisted small-specimen imaging as an integrated solution is a natural next move for our Maestro Encore platform. Lumea's proven digital pathology expertise aligns perfectly with our purpose to enrich life by building the platform to transform the treatment of disease."
"We're excited to partner with Mopec and infuse innovation directly into a pathologist's daily workflow," said James Thackeray, CEO of Lumea. "The grossing station is one of the most critical touchpoints in the pathology journey. Using digital tools at this stage transforms efficiency, consistency, and ultimately, patient care."
In addition to integrating the Lumea BxCamera into every station, Mopec Group and Lumea plan to co-develop next-generation solutions that bring together small and large format imaging systems within the Maestro Encore grossing station as a platform built specifically for the evolving needs of digital pathology.
Together, Mopec Group and Lumea are helping pathology professionals move beyond the limitations of analog tools—bringing intelligence, automation, and seamless integration to one of the most critical stages of the diagnostic journey. This collaboration reflects Mopec Group's vision to shape a future where advanced tools and technology drive better patient outcomes and redefine how disease is diagnosed in the lab.
About Mopec Group
Mopec Group, headquartered in Madison Heights, Michigan, is a vertically integrated, branded supplier and manufacturer of high-quality anatomic and forensic pathology equipment, technology, consumable products, and services. Founded in 1992, Mopec Group differentiates itself through its innovation, engineering excellence, and outcome-focused mindset. Mopec Group is elevating pathology with complete solutions for labs in hospitals, universities, morgues, and beyond. For more information, visit www.mopecgroup.com and www.Mopec.com.
About Lumea
Lumea is powering efficient, affordable, and accessible digital pathology through simplified, workflow-driven innovation with both tissue-handling technology and a best-in-class viewer with AI-driven workflows. As the U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide. With over a decade of expertise, Lumea has set the standard for efficiency, quality, and premium cancer diagnostics. With a global presence spanning five continents, Lumea supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity, boosting detection rates, and delivering measurable ROI. By placing patients at the core, Lumea is transforming pathology for a more precise and efficient future. Learn more at www.lumeadigital.com.
Media Contact:
Jeff Pemberton
Vice President of Marketing & Commercial Strategy
[email protected]
o. 248.284.0871 | c. 810.300.2157
Bianca Collings
Lumea VP, Head of Marketing
[email protected]
SOURCE Mopec
Share this article